(lp0
S"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Novartis Motley Fool - Mar 7, 2017 Few companies can claim to have helped improve more individuals' eyesight than Regeneron Pharmaceuticals  and Novartis .Vetr Downgrades Regeneron To Buy Off Of Price Rise - BenzingaREGENERON PHARMACEUTICALS,INC.  Files An 8-K Entry into a ... - Market Exclusive"
p1
aS'Regeneron Pharmaceuticals Inc  Upgraded by Vetr Inc. to Strong-Buy Chaffey Breeze - 5 hours ago Regeneron Pharmaceuticals logo Regeneron Pharmaceuticals Inc  was upgraded by analysts at Vetr from a buy rating to a strong-buy rating in a research note issued on Wednesday.The Regeneron Pharmaceuticals Inc  PT Set at $446.00 by Piper Jaffray ... - Petro Global News 24UBS Initiates Coverage On Regeneron Pharmaceuticals Inc to Buy with Price ... - Energy Index'
p2
aS'Teen Scientist Researches New Approach to Neurological Damage; Wins Regeneron ... PR Newswire  - Mar 15, 2017 WASHINGTON, March 14, 2017 /PRNewswire/ -- Society for Science &amp; the Public and Regeneron Pharmaceuticals, Inc.  announced that Indrani Das, 17, of Oradell, New Jersey, won the top award in the Regeneron Science Talent Search,&nbsp;...'
p3
aS'Regeneron Pharmaceuticals Inc Realized Volatility Hits A Rock Bottom Low CML News - 14 hours ago This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for Regeneron Pharmaceuticals Inc  . We examine the little used gem of daily stock volatility ...'
p4
aS"Regeneron Pharmaceuticals Inc And Sanofi's See Big Dermatitis Drug Progress StockNews.com  - Mar 6, 2017 Regeneron Pharmaceuticals Inc , along with its development partner Sanofi, this morning presented some detailed results from the latest study for their breakthrough dermatitis treatment.Regeneron Pharmaceuticals, Inc.  and Sanofi presented results ... - KC RegisterRegeneron, Sanofi: DUPIXENT Study In Atopic Dermatitis Shows Positive Data - Nasdaq"
p5
aS"Recent Update on Price Movements: Regeneron Pharmaceuticals, Inc.  Is stories - 18 hours ago Regeneron Pharmaceuticals, Inc.'s  witnessed a gain of 0.57% in recent trading period with closing price of $ 391.10."
p6
aS"Regeneron Pharmaceuticals Inc.  Dips 2.5% for February 23 Equities.com - Feb 23, 2017 Among the S&amp;P 500's biggest fallers on Thursday February 23 was Regeneron Pharmaceuticals Inc. . The stock experienced a 2.5% decline to $360.96 with 1.12 million shares changing hands."
p7
aS'Regeneron Pharmaceuticals Inc.  Rises 3.34% for February 27 Equities.com - Feb 27, 2017 Among the biggest risers on the S&amp;P 500 on Monday February 27 was Regeneron Pharmaceuticals Inc. , popping some 3.34% to a price of $373.05 a share with some 537,859 shares trading hands.How has Regeneron Pharmaceuticals, Inc.: performed recently? - The Daily LeicesterThe Asset Management One Co. Ltd. Boosts Position in Regeneron Pharmaceuticals ... - DailyQuint'
p8
aS"Regeneron Pharmaceuticals Inc.  Dips 2.86% for February 16 Equities.com - Feb 16, 2017 Among the S&amp;P 500's biggest fallers on Thursday February 16 was Regeneron Pharmaceuticals Inc. . The stock experienced a 2.86% decline to $373.02 with 1.28 million shares changing hands.Regeneron Pharmaceuticals, Inc.  PT Lowered to $410.00 at Sanford C ... - BNB Daily Analytical Guide for EQT Corporation , Regeneron Pharmaceuticals, Inc ... - The USA Commerce"
p9
aS'Price Target Of Regeneron Pharmaceuticals, Inc.  Set At $428.285 Transcript Daily - 17 hours ago Analysts have placed a $428.285 1-year price target on Regeneron Pharmaceuticals, Inc. . It is the average based on 14 firms who have allowed ratings on the equity.'
p10
a.